Skip to content Accessibility tools
Contrast
AaFont Size

Higher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients With COVID-19

Share Download

Source: JAMA

Study describing the use of Fluvoxamine, an SSRI, in the treatment of COVID-19

Read

Audience

Patient
Provider

Domains

Current Evidence-Based Guidance

Formats

Read

Related Resources

Current Evidence-Based Guidance

COVID-19 in children, pediatric, clinical management of children with COVID-19

Read
PatientProvider

Current Evidence-Based Guidance

COVID-19, variants, cases, new variant

Read
PatientProvider

Current Evidence-Based Guidance

COVID-19 testing, COVID-19 current treatment, COVID-19 variants, testing guidelines

Read
PatientProvider